(Abstracted from Lancet Gastroenterol Hepatol 2021;6:547–558) Ursodeoxycholic acid (UA) is a common treatment for intrahepatic cholestasis of pregnancy (ICP), and its use supported by the Society Maternal-Fetal Medicine. However, evidence benefit UA to fetal neonatal outcomes in this patient population unclear.

s of 18th European Crystallographic Meeting, Praha, Czech Republic, 1998a. 24. R. S. Mulliken, Phys. Rev., 43, 279 (1933). 25. D. Orobengoa, C. Capillas, M. I. Aroyo, J. M. PerezMato, J. Appl. Cryst. A, 42, 820 (2009). 26. J. M. Perez-Mato, Orobengoa, M. I. Aroyo, Acta Cryst. A, 66, 558 (2010). 27. G. Wintgen, Math. Ann., 118, 195 (1941) (in

COX inhibitors which selectively inhibits the inducible COX-2 is an oenzyme that causes inflammation. They are clinically effective anti-inflammatory agents with less gastrointestinal and renal toxicity. However, they lack anti-thrombotic activity and hence lead to increased incidences of adverse cardiovascular trombotic events such as myocardial infarction. Therefore, there is still a need to ...

1 Médecin Généraliste, Département Universitaire de Médecine Générale, Faculté de Médecine et Université de Toulouse, Toulouse, France 2 Service de Pharmacologie Clinique, Centre Midi-Pyrénées de PharmacoVigilance, de Pharmacoépidémiologie et d’Informations sur le Médicament, Centre Hospitalier Universitaire, Toulouse, France 3 Laboratoire de Pharmacologie Médicale et Clinique, Unité de Pharmac...

Sourcing complexity factors on contractual relationship: Chinese suppliers’ perspective Nachiappan Subramanian, Muhammad D. Abdulrahman & Shams Rahman To cite this article: Nachiappan Subramanian, Muhammad D. Abdulrahman & Shams Rahman (2014) Sourcing complexity factors on contractual relationship: Chinese suppliers’ perspective, Production & Manufacturing Research, 2:1, 558-585 To link to this...